Gabapentin in the treatment of fibromyalgia: A randomized, double‐blind, placebo‐controlled, multicenter trial

M. Arnold, Lesley; L. Goldenberg, Don; B. Stanford, Sharon; Lalonde, Justine; S. Sandhu, Harvinder; E. Keck, Paul; A. Welge, Jeffrey; Bishop, Fred; E. Stanford, Kevin; V. Hess, Evelyn; I. Hudson, James

doi:10.1002/art.22457

Public

Gabapentin in the treatment of fibromyalgia: A randomized, double‐blind, placebo‐controlled, multicenter trial

Published in Arthritis & Rheumatism • Mar 28, 2007

Authors:

Lesley M. Arnold

Don L. Goldenberg

Sharon B. Stanford

Abstract

OBJECTIVE: To assess the efficacy and safety of gabapentin in patients with fibromyalgia. METHODS: A 12-week, randomized, double-blind study was designed to compare gabapentin (1,200-2,400 mg/day) (n=75 patients) with placebo (n=75 patients) for efficacy and safety in treating pain associated with f...

Subject

Gabapentin

Medicine

Brief Pain Inventory

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!